Day: July 11, 2023

VOLT LITHIUM CORP. FILES PRELIMINARY SHORT FORM BASE SHELF PROSPECTUS

VOLT LITHIUM CORP. FILES PRELIMINARY SHORT FORM BASE SHELF PROSPECTUS

Calgary, Alberta, Canada, July 11, 2023 (GLOBE NEWSWIRE) — Volt Lithium Corp. (TSX-V: VLT, OTCQB: VLTLF, FSE: I2D) (“Volt” or the “Company”) is pleased to announce it has filed and obtained a receipt for a preliminary short form base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada, except Québec. Upon a (final) short form base shelf prospectus (the “Prospectus”) becoming effective, these filings, subject to securities regulatory requirements, will allow the Company and certain of its securityholders to qualify the distribution of up to C$100 million of common shares, preferred shares, debt securities, warrants, subscription receipts, and units, or any combination thereof (collectively, the “Securities”) during the 25-month period that the Prospectus is effective, in amounts, at prices...

Continue reading

Bowen Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

Bowen Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) — Bowen Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, July 12, 2023, under the ticker symbol “BOWNU.” Each unit consists of one ordinary share and one right entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of an initial business combination, subject to adjustment. Once the securities comprising the units begin separate trading, ordinary shares and redeemable warrants are expected to be listed on Nasdaq under the symbols “BOWN” and “BOWNR,” respectively.  Bowen Acquisition Corp is a Cayman exempt company formed as a blank check company for the purpose of entering...

Continue reading

Eddy Smart Home Solutions Ltd. (formerly Aumento Capital VIII Corp.) Announces Year Ended and Q4/2022 results

Eddy Smart Home Solutions Ltd. (formerly Aumento Capital VIII Corp.) Announces Year Ended and Q4/2022 results

TORONTO, July 11, 2023 (GLOBE NEWSWIRE) — Eddy Smart Home Solutions Ltd. (formerly Aumento Capital VIII Corp.) (“Eddy” or the “Company”) (TSXV: EDY) released its financial statements for the three and twelve months ended December 31, 2022. REVENUE Revenue for the three months ended December 31, 2022, increased by $631,457 to $885,648 as compared with $254,191 reported for the comparable quarter in 2021.  Revenue for the year ended December 31, 2022, increased by $1,341,016 to $2,563,852 as compared with to $1,222,836 reported for the comparable period in 2021. NET LOSS  Net loss for the three months ended December 31, 2022, was ($3,770,340), as compared to ($1,860,472) reported for the comparable period.   Net loss for the year ended December 31, 2022, was ($11,800,950), excluding the nonrecurring, non-cash...

Continue reading

Euronet Announces Second Quarter 2023 Earnings Release Date and Conference Call Details

Euronet Announces Second Quarter 2023 Earnings Release Date and Conference Call Details

LEAWOOD, Kan., July 11, 2023 (GLOBE NEWSWIRE) — Euronet (or the “Company”) (NASDAQ: EEFT) announced today it will release second quarter 2023 earnings results prior to the market opening on Wednesday, July 26, 2023. Euronet will hold a conference call the same day at 9:00 a.m. Eastern Time to discuss the results. The conference call and accompanying slide show presentation will be accessible via webcast by following the link posted on http://ir.euronetworldwide.com. Participants wanting to access the conference call by telephone must register at   Euronet Worldwide Second Quarter 2023 Earnings Call to receive dial-in information. While not required, it is recommended participants join the call five minutes prior to the event start. A webcast replay will be available beginning approximately one hour after the event at http://ir.euronetworldwide.com...

Continue reading

Banco Santander Chile: Announces Second Quarter 2023 Analyst and Investor Webcast / Conference Call

Banco Santander Chile: Announces Second Quarter 2023 Analyst and Investor Webcast / Conference Call

SANTIAGO, Chile, July 11, 2023 (GLOBE NEWSWIRE) — You are cordially invited to participate in Banco Santander Chile’s (NYSE: BSAC) conference call-webcast on Friday, August 4, 2023, at 11.00 AM (Eastern Time) where we will discuss 2Q 2023 financial results. The Bank’s Officers participating in the conference call are: Emiliano Muratore, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR and Claudio Soto, Chief Economist. A question and answer session will follow the presentation. The Management Commentary report will be published on July 31, 2023, before the market opens. The quiet period begins on July 17. To participate, the webcast presentation can be viewed at: https://mm.closir.com/slides?id=720987 Or please dial in using any of the below numbers: United Kingdom+44 203 984 9844 USA+1 718 866 4614 Austria+43...

Continue reading

ThreeD Capital Inc. Announces Unaudited June 30, 2023 Net Asset Value Per Share - $0.75

ThreeD Capital Inc. Announces Unaudited June 30, 2023 Net Asset Value Per Share – $0.75

TORONTO, July 11, 2023 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at June 30, 2023, its unaudited net asset value per share (“NAV”) was $0.75.   This announcement is made based on ThreeD’s established practice of releasing NAV on a monthly basis as part of the Company’s ongoing response to shareholder interest in receiving periodic information. NAV is calculated based on unaudited month-end financial information. Use of Non-GAAP Financial Measures: This press release contains references to NAV or “net asset value per share” which is a non-GAAP financial measure. NAV is calculated as the value of total assets less the value...

Continue reading

Kinross to redeem $500 million in Senior Notes on August 10, 2023

Kinross to redeem $500 million in Senior Notes on August 10, 2023

(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.) TORONTO, July 11, 2023 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX:K; NYSE:KGC) (“Kinross”) announced today it will redeem all of the outstanding 5.95% Senior Notes due March 15, 2024 (the “Notes”), which have an aggregate principal amount of $500 million, on August 10, 2023 (the “Redemption Date”). The Notes will be redeemed at a redemption price determined in accordance with the terms of the Notes and will include accrued and unpaid interest to, but not including, the Redemption Date. Interest on the Notes will cease to accrue from and after the Redemption Date. After the Notes are redeemed, Kinross will have $1,250 million aggregate principal amount of Senior Notes outstanding, with the next Senior Notes maturity date on July 15, 2027 for $500...

Continue reading

embecta to Report Fiscal Third Quarter 2023 Financial Results

embecta to Report Fiscal Third Quarter 2023 Financial Results

PARSIPPANY, N.J., July 11, 2023 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal third quarter 2023 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, August 8, 2023. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on August 8, 2023, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to...

Continue reading

ReWalk Robotics Ltd. to Present at the Emerging Growth Conference on July 12

ReWalk Robotics Ltd. to Present at the Emerging Growth Conference on July 12

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , July 11, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) announced Larry Jasinski, Chief Executive Officer, will present virtually at the Emerging Growth Conference at 10:15 am EDT on Wednesday, July 12, 2023. For investors who are interested in participating, please use the link below to register and receive any conference updates: https://goto.webcasts.com/starthere.jsp?ei=1603282&tp_key=1cd1dcc46a&sti=rwlk  For attendees who are unable to join the event live, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, An archived link to the presentation will be available on the Company’s website after the event. About ReWalk Robotics Ltd.: ReWalk Robotics Ltd. is a medical device...

Continue reading

Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems

Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems

SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the company’s Chief Scientific Officer, David Friend, Ph.D., will present during the Novel Drug Delivery Technologies, Systems and Devices section of the 9th Annual International Symposium of Drug Delivery Systems being held July 12-14, 2023, in Amsterdam, the Netherlands. Dr. Friend’s presentation, entitled “Vaginal Rings: Expanding Drug Delivery Options for Women,” is scheduled for Wednesday, July 12th at 2:15 p.m. CEST. The intravaginal ring (IVR) technology used in Daré’s clinical-stage product candidates, DARE-HRT1, a potential first-in-category product for treatment of vasomotor symptoms due to menopause designed to release bio-identical estradiol and bio-identical progesterone over...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.